Skip to content

Geron GERN Other income, net (Note 6)

Other income, net (Note 6) at other companies

Bristol-Myers Squibb logo
Bristol-Myers SquibbBMY
-$32M+90.6%
Syndax Pharmaceuticals logo
Syndax PharmaceuticalsSNDX
-$186K+15.8%
Tango Therapeutics logo
Tango TherapeuticsTNGX
$1.08M+0.5%
Cogent Biosciences, Inc. logo
Cogent Biosciences, Inc.COGT
-$140K-2,700%
Incyte logo
IncyteINCY
Exelixis logo
ExelixisEXEL

Other financials

Income statement

See full
Revenue$51.8M+30.9%
Operating income$158.0K+101%
Net income-$3.6M+81.6%
EPS (diluted)-$0.01+66.7%

Balance sheet

See full
Cash & equivalents$48.7M-12.2%
Total debt$134.0M+10.0%
Total equity$229.1M-14.6%
Total assets$534.1M-5.0%

Cash flow

See full
Operating cash flow-$62.9M-31.1%
CapEx$206.0K+2.0%
Free cash flow-$43.8M-6.8%

Valuation

See full
Market cap$878.88M-8.6%
Enterprise value$964.15M-6.2%
P/S4.7×-172×

Profitability

See full
Operating margin-705.5%-351pp
Net margin-682.5%-339pp
FCF margin-734.4%-365pp

Returns & leverage

See full
Return on equity-27.1%-7.8pp
Debt / equity0.6×+0.1×
Current ratio6.8×-1.1×

Where this comes from

Reported directly by Geron in its filing.

Tagged under the XBRL concept us-gaap:OtherNonoperatingIncomeExpense.

The official record: Geron’s 10-Q, filed May 6, 2026, on SEC EDGAR. View the filing →

Ask your AI about Geron's other income, net (note 6).

Connect your AI assistant and compare it to peers, right in your chat.

Connect your AI
Harbor at dusk
Claude

Questions, answered.

What is Geron's other income, net (note 6)?
Geron (GERN) reported other income, net (note 6) of -$74K in Q1 2026.
How has Geron's other income, net (note 6) changed year-over-year?
Geron's other income, net (note 6) increased by 10.8% year-over-year, from -$83K to -$74K.
What is the long-term trend for Geron's other income, net (note 6)?
Over 3 years (2021 to 2025), Geron's other income, net (note 6) has grown at a -30.3% compound annual growth rate (CAGR), from $1.11M to -$375K.
What does other income, net (note 6) mean?
This captures miscellaneous financial items that fall outside the scope of core operating activities, such as foreign exchange gains or losses, minor investment income, or non-recurring legal settlements. It serves as a catch-all for peripheral financial events that do not stem from the primary business operations. Investors monitor this to isolate core earnings from transient or incidental financial fluctuations.